Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Éva Compérat, Mahul B. Amin, Richard Cathomas, et al.
The Lancet (2022) Vol. 400, Iss. 10364, pp. 1712-1721
Open Access | Times Cited: 216

Showing 101-125 of 216 citing articles:

Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series
Akifumi Omiya, Satoshi Nitta, Shuya Kandori, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102149-102149
Closed Access | Times Cited: 1
Leveraging programmed cell death signature to predict clinical outcome and immunotherapy benefits in postoperative bladder cancer
Yifan Wang, Qi Zhang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy
Yi Tang, Ye Tian, Chun‐Xia Zhang, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access | Times Cited: 1
Comparative analysis of amide proton transfer and diffusion-weighted imaging for assessing Ki-67, p53 and PD-L1 expression in bladder cancer
Jing‐Lu Li, Yun Xu, Yong‐Sheng Xiang, et al.
Academic Radiology (2024)
Closed Access | Times Cited: 1
The Value of Multi-directional High b-Value DWI in the Assessment of Muscular Invasion in Bladder Urothelial Carcinoma: In Comparison with VI-RADS
Xiaoxian Zhang, Yun You, Shaoyu Wang, et al.
Academic Radiology (2024)
Closed Access | Times Cited: 1
Use of artificial intelligence to enhance detection of nodal metastases
Reza Forghani
The Lancet Oncology (2023) Vol. 24, Iss. 4, pp. 308-309
Closed Access | Times Cited: 4
Klotho in Cancer: Potential Diagnostic and Prognostic Applications
Jucileide Mota, Alice Marques Moreira Lima, Jhessica I. S. Gomes, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3357-3357
Open Access | Times Cited: 4
METTL3 regulates the proliferation, metastasis and EMT progression of bladder cancer through P3H4
Chunhui Liu, Junjie Zhang, Qian-Jin Zhang, et al.
Cellular Signalling (2023) Vol. 113, pp. 110971-110971
Closed Access | Times Cited: 4
Molecular map of cGAS-STING pathway-related genes in bladder cancer: the perspective toward immune microenvironment and prognosis
Wei Dong, Ying Liu, Ying Yuan, et al.
Aging (2024)
Open Access | Times Cited: 1
Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway
Kai Wang, Wen Xiao, Qi Zeng
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 71-71
Open Access | Times Cited: 1
Molecular profiling of a bladder cancer with very high tumour mutational burden
Manuel Scimeca, Julia Bischof, Rita Bonfiglio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Strategically Staged Tumor Ablation and Inflammation Suppression Using Shell‐Core Nanoparticles to Eradicate Bladder Tumors and Prevent Recurrence
Yong Xu, Ruiyun Zhang, Junjie Zhu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 37
Closed Access | Times Cited: 1
CRISPR-based gene expression platform for precise regulation of bladder cancer
Tianying Zhan, Xiao Li, Jiumin Liu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
PA-MSHA improves prognosis of patients undergoing radical cystectomy: a retrospective cohort study using inverse probability of treatment weighting
Xiaohua Zhang, Zixu Pei, Jinglei Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Revitalizing BCG Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches
M. Lv, S. Y. Shang, Kepu Liu, et al.
(2024)
Open Access | Times Cited: 1
m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis
Kaixuan Du, Yongbo Luo, Lei Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 40, pp. 2971-2985
Closed Access | Times Cited: 1
Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling
Chunyu Zhang, Jiao Hu, Liu Zhi, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies
Wenjie Ma, Xiaotian Jiang, Ruipeng Jia, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer
Xingyu Shi, Wenbin Zheng, Binhong He, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120022-120022
Closed Access | Times Cited: 1
Silencing CCT3 induces ferroptosis through the NOD1-NF-κB signaling pathway in bladder cancer
Jianlin Huang, Yizhao Luo, Yu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?
Fernando Bril, Alicia Elbert
Metabolism (2024), pp. 156066-156066
Closed Access | Times Cited: 1
Prognostic Significance of CCDC8 in Bladder Cancer: Insights from Bioinformatics and Immunohistochemical Analysis
Xiaojie Zhao, Xin Yu, Wenge Li, et al.
Journal of Cancer (2024) Vol. 16, Iss. 2, pp. 382-397
Closed Access | Times Cited: 1
N6-methyladenosine-modified SRD5A3, identified by IGF2BP3, sustains cisplatin resistance in bladder cancer
Kai Liao, Jing Li, Cai-Xian He, et al.
Human Cell (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Manuel Sánchez-Cánovas, David Fernández Garay, Evdochia Adoamnei, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 10, pp. 3021-3031
Open Access | Times Cited: 3
Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium
Flor Verghote, Charles Van Praet, Daan De Maeseneer, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 511-521
Open Access | Times Cited: 3

Scroll to top